5 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow PSMA ADC: new trials by email Literature Review of PSMA ADC trials Research Report on PSMA ADC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Extension Study of PSMA ADC 2301 in mCRPC PSMA ADC - Prostate Cancer | Phase 2 | Completed | Progenics Pharmaceuticals, Inc. | 9 | 2013-10-01 | 2017-03-24 |
| BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) PSMA ADC - GBM, Glioblastoma Multiforme | Phase 2 | Completed | Heinrich Elinzano, MD | 6 | 2013-05-01 | 2021-11-23 |
| A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) PSMA ADC - Prostate Cancer | Phase 2 | Completed | Progenics Pharmaceuticals, Inc. | 119 | 2012-09-01 | 2017-03-24 |
| Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer PSMA ADC - Prostate Cancer | Phase 1 | Completed | Progenics Pharmaceuticals, Inc. | 10 | 2009-01-01 | 2013-11-14 |
| Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer PSMA ADC - Prostate Cancer | Phase 1 | Completed | Progenics Pharmaceuticals, Inc. | 52 | 2008-10-01 | 2013-11-01 |
Prostatic Neoplasms (4) · Glioblastoma (1) · Gliosarcoma (1)
Progenics Pharmaceuticals, Inc. (4) · Heinrich Elinzano, MD (1)
United States (5)
Robert J Israel, MD (2) · Vivien Wong, PhD (2) · Heinrich Elinzano, MD (1)